Fennec Pharmaceuticals Inc. (TSX:FRX)
Canada · Delayed Price · Currency is CAD 15.04
-0.25 (-1.64%)
Sep 24, 2026, 3:56 PM EST
Fennec Pharmaceuticals Market Cap
Fennec Pharmaceuticals has a market cap or net worth of CAD 526.88 million as of September 25, 2026. Its market cap has increased by 61.23% in one year.
Market Cap
526.88M
Enterprise Value
468.52M
Revenue
84.10M
Ranking
n/a
PE Ratio
n/a
Stock Price
15.04
ChartMarket Cap Chart
Since November 12, 2004, Fennec Pharmaceuticals's market cap has increased from 89.84M to 526.88M, an increase of 486.50%. That is a compound annual growth rate of 8.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 526.88M | 46.12% |
| Dec 31, 2025 | 360.58M | 44.35% |
| Dec 31, 2024 | 249.80M | -36.88% |
| Dec 29, 2023 | 395.77M | 15.99% |
| Dec 30, 2022 | 341.20M | 135.62% |
| Dec 31, 2021 | 144.81M | -40.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bright Minds Biosciences | 854.92M |
| Eupraxia Pharmaceuticals | 796.15M |
| Satellos Bioscience | 269.02M |
| Eastwood Bio-Medical Canada | 126.06M |
| Helix BioPharma | 89.36M |
| NurExone Biologic | 61.69M |
| ME Therapeutics Holdings | 53.18M |
| BriaCell Therapeutics | 49.94M |